Stereotactic Body Radiation Therapy for Prostate-Specific Antigen
This trial is testing apalutamide with or without radiation therapy to see if it can effectively treat prostate cancer that is no longer responding to hormone therapy.
- Prostate-Specific Antigen Progression
- Castration-resistant Prostate Cancer
- Prostate Cancer (Stage IV)
- Low Testosterone
1 Primary · 2 Secondary · Reporting Duration: Up to 36 months
2 Treatment Groups
Arm II (SBRT)
1 of 2
Arm I (apalutamide, SBRT)
1 of 2
60 Total Participants · 2 Treatment Groups
Primary Treatment: Stereotactic Body Radiation Therapy · No Placebo Group · Phase 2
Who is running the clinical trial?
Age 18+ · Male Participants · 22 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Is this an innovative or revolutionary clinical trial?
"Since 2014, Aragon Pharmaceuticals have sponsored research into Stereotactic Body Radiation Therapy. Following a successful trial involving 982 people in that year, the drug received Phase 3 approval. Currently there are 44 active clinical trials for this therapy being conducted across 552 cities and 38 countries worldwide." - Anonymous Online Contributor
Is Stereotactic Body Radiation Therapy licensed by the FDA?
"Our assessment at Power assigned Stereotactic Body Radiation Therapy a score of 2, signifying there is evidence for its safety but not yet enough for efficacy." - Anonymous Online Contributor
Is there still an opportunity to join this clinical research?
"Affirmative. Information from clinicaltrials.gov reveals that this trial, first posted on December 17th 2019, is currently recruiting participants. Approximately 60 individuals are needed at 1 medical centre to take part in the research." - Anonymous Online Contributor
What has been the experience with Stereotactic Body Radiation Therapy in previous experiments?
"Presently, 44 trials for Stereotactic Body Radiation Therapy are in progress with 15 of those Phase 3. The majority of these tests take place at a single site in South Weymouth, Massachusetts; however, there are 2417 other locations running studies related to this therapy." - Anonymous Online Contributor
To what extent is participant recruitment for this clinical trial progressing?
"Affirmative. According to clinicaltrials.gov, this medical experiment is actively enrolling participants; it was first posted on December 17th 2019 and its most recent modification took place on August 29th 2022. Sixty individuals need to be recruited from a single site for the study's completion." - Anonymous Online Contributor